Antibiotic coating of implants
An antibiotic coating of implants is described, which is characterized in that the coating comprises at least one saturated, organic, hydrophobic, low molecular matrix former whose melting point is in the temperature range of 45° C. to 100° C., in which a low molecular, hydrophobic additive is dissolved and that an antibiotic/antibiotics is/are suspended in the mixture of matrix former and additive and/or in which an antibiotic/antibiotics miscible with a mixture of matrix former and additive is/are dissolved.
1. Antibiotic coating of implants wherein the coating comprises a mixture of at least one saturated, organic, hydrophobic, low molecular matrix former selected from the group consisting of glycerine tristearate, glycerine tripalmitate, glycerine trimyristate, glycerine tribehenate, stearic acid, palmitic acid, myristic acid, behenic acid, myristyl palmitate, cetyl palmitate, ceryl cerotinate and glycerine triester, wherein each ester of said triester is formed from an even numbered fatty acid that is different from the other esters of said trimester, and whose melting point is within the temperature range of 45° C. to 100° C., in which a low molecular, hydrophobic additive selected from the group consisting of stearic acid, palmitic acid, and myristic acid is dissolved and that, in the mixture of matrix former and hydrophobic additive, at least one antibiotic is suspended and/or at least one antibiotic miscible with the mixture of matrix former and hydrophobic additive is dissolved.
2. Antibiotic coating of implants according to claim 1 , wherein the coating is present in a solid state of aggregation in a temperature range of 20° C. to 45° C. and can be subjected to plastic deformation by pressure forces and shear forces.
3. Antibiotic coating of implants according to claim 1 , wherein the antibiotic is one or more of gentamicin sulphate, tobramycin sulphate, amikacin sulphate, netilmicin sulphate, sisomycin sulphate, vancomycin hydrochloride, teicoplanin, ramoplanin, clindamycin hydrochloride, lincomycin hydrochloride, metronidazole, tinidazole, gentamicin palmitate, gentamicin myristate, gentamicin laurate, tobramycin palmitate, tobramycin myristate, amikacin palmitate, amikacin myristate, amikacin laurate, linezolide, chlorohexidine stearate, chlorohexidine palmitate, chlorohexidine laurate, griseofulvin, nytatin, fuconazole, moxifloxazole, ciprofloxacin, fusidinic acid, rifampicin, rifamycin, fosfomycin, cycloserine, polyhexanide and trichlosan.
4. Antibiotic coating of implants according to claim 1 , wherein the coating is formed of 1.0-98.0 percent by weight of at least one saturated, organic, hydrophobic, low molecular matrix former whose melting point is in the temperature range of 45° C. to 100° C., 0.1-5.0 percent by weight of low molecular, hydrophobic additive and 0.1-5.0 percent by weight of antibiotic/antibiotics.
5. Process for coating implants antibiotically comprising heating a composition of the matrix former, the hydrophobic additive and the at least one antibiotic according to claim 1 to a temperature greater than the melting point of the matrix former to form a suspension or a homogeneous melt and immersing the implant into the suspension or the homogenous melt formed, the implant having been first heated to a temperature at least 10° C. higher than the melting point of the matrix former and, subsequently, cooling the coated implant to room temperature.
6. Process for coating implants antibiotically comprising dissolving a mixture of the matrix former, the hydrophobic additive and the at least one antibiotic according to claim 1 in an organic solvent to form a solution and, subsequently, spraying the solution onto an implant, the implant having been heated, before spraying, to a temperature at least 10° C. higher than the melting point of the matrix former and at least 10° C. higher than the boiling point of the organic solvent and, subsequently, cooling the coated implant to room temperature.
7. Process for coating implants antibiotically comprising applying a mixture of the matrix former, the hydrophobic additive and the a least one antibiotic according to claim 1 as a layer onto an implant surface wherein the mixture applied is heated to a temperature of at least the melting point of the matrix former.
8. Process for coating implants antibiotically comprising forming a mixture of the matrix former, the hydrophobic additive and the at least one antibiotic according to claim 1 into a solid compact body, rubbing the body onto the surface of an implant and, as a result, separating off a coating on the implant surface and, optionally, heating the coated implant to a temperature of at least the melting point of the matrix former.
9. An implant coated with the coating according to claim 1 .